Debts
€450,820 81% of the balance sheet
Financial debts 83%Suppliers 2%Taxes and wages 1%Other 14%
Of this, €75,158 falls due within a year.
DNCL
Lifetime
6 annual accounts with figures on one time axispeak €73,207 (2024)
€36,151▼ 50.6%
lowest -€21,999 (2025)
-€21,999▼ €36,562
peak €124,870 (2024)
€102,872▼ 17.6%
€450,820▼ 2.3%
Board1 name since 2020
1 director
Documentsfilings and deeds
10-07-202621 days before the deadline
2025micro format
Gross margin from €73,207 to €36,151Loss of €21,999Equity from €124,870 to €102,872Cash from €19,730 to €8,002
Key points
from the 2025 annual accountsFilings
6 annual accounts 4 late
The 2022 accounts came latest: 57 days after the end of the period.
Position in the sector
-€21,999
Lower net result than 95% of companies in human health. Sector median €59,543 · 21,321 companies.
Checked score
Bankruptcy probability within 12 months
Financial strength
Score breakdown
Comparable companies, two years later
In July 2024, 748 companies had the same profile as DNCL has now. Each dot stands for 2 companies, two years later.
96.7%
were still trading
1.9%
stopped another way
1.3%
went bankrupt
Another 0.1% stopped without a precise date, possibly only after those two years.
Test of the method
The method was tested on the 497,762 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 2.9% | 3.1% |
| 10 | 5.6% | 6.1% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 748 companies, not a prediction for DNCL. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit verdict
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Board and ownership
Director, since 11-02-2020
- 226 sharesdeed of 13-02-2020
- 74 sharesdeed of 13-02-2020
Recent changes
Registered in the Peppol Directory
Reachable for e-invoices through 0208:0743549540
Registered office moved within Zwevegem
New registered office: Deerlijkstraat 139, 8550 Zwevegem · Previous registered office: Acacialaan 34, 8550 Zwevegem, België · Board meeting of 30-04-2024 · Gazette deed
Incorporation
Founders: and · 300 shares · Appointment: (director) · published on 13-02-2020 · Gazette deed
First establishment
Deerlijkstraat 139, Zwevegem
Comparable companies
same main activity, similar in size and age| Company | ||||
|---|---|---|---|---|
| DNCL Zwevegem | €553,692 | €36,151 | 18.6% | - |
| KOM & LEER Ostend | €517,162 | €45,933 | 11.6% | - |
| KINESITHERAPIE LISA COUCKE Kortrijk | €751,938 | €37,507 | 17.3% | - |
| Eline Daelemans Antwerp | €535,688 | €39,076 | 8.0% | - |
| VALANCO MEDICAL Schilde | €558,679 | €35,016 | 19.1% | - |
| GC Mechelen Mechelen | €647,405 | €34,166 | 0.2% | - |
| Podologie Claeys Lievegem | €396,023 | €39,029 | 6.6% | - |
These companies have the same main activity as DNCL: physiotherapy (NACE 86951). They are comparable in size and age: total assets between €396,000 and €752,000, founded between 2019 and 2021.
Official details
Source: KBO- Status
- Active since 11-02-2020Normal situation
- Activity
- PhysiotherapyNACE 86951and 1 other
- Establishment unit
- 2.300.694.3028550 Zwevegem, since 11-02-2020
- Financial year end
- 31 December
- Peppol
- Reachable since 01-12-2025
Annual accounts 2025
- ≈ €110,000estimated
- €553,692▼ 5.6%
- Filing
- Filed on 10-07-2026, 21 days before the end of the filing period
Insights on DNCL
DNCL files the micro format. That format states no turnover. The gross margin rose from €32,055 in 2020 to €36,151 in 2025.
Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.
Key facts about DNCL
- What is the company number of DNCL?
- The company number of DNCL is 0743.549.540. The VAT number is the same number with BE in front: BE 0743.549.540.
- Where is DNCL based?
- The registered office is at Deerlijkstraat 139, 8550 Zwevegem.Company details
- What does DNCL do?
- According to the KBO register, the main activity is physiotherapy (NACE 86951).
- What is the legal form of DNCL?
- DNCL is a private limited company (BV).
- When was DNCL founded?
- DNCL was founded on 11-02-2020.
- Is DNCL still active?
- Yes, DNCL is an active enterprise in the KBO register.
- What is the turnover of DNCL?
- The turnover in financial year 2025 is ≈ €110,000. This figure is estimated from the gross margin of €36,151 and 34 comparable companies (NACE 869). It probably lies between €83,000 and €150,000.Financials
- Is DNCL profitable?
- In financial year 2025, DNCL made a loss of €21,999.
- Where can I find the annual accounts of DNCL?
- DNCL filed 6 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of DNCL due?
- DNCL must file the annual accounts for financial year 2026 by 31-07-2027.Timeline
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Check which of your other customers you can e-invoice via Peppol.Peppol check Compare this company with its sector.Sector benchmark See what changed in the latest annual accounts.What changed
See how customers, suppliers and banks see your own company and what to improve first.